75
Participants
Start Date
November 30, 2010
Primary Completion Date
August 31, 2011
Study Completion Date
August 31, 2011
Seroquel XR- quetiapine fumarate extended release
Seroquel XR dose 400-700 mg (in tablet form). The investigator established the dosing schedule for each patient depending on the patient's dose when entering the study. The patients continued on the same dose during the study as they had prior to enrolment. Dose taken once a day for 10-16 days.
Seroquel IR - quetiapine fumarate
Seroquel IR dose 400-700 mg (in tablet form). The investigator established the dosing schedule for each patient depending on the patient's dose when entering the study. The patients continued on the same dose during the study as they had prior to enrolment. Dose taken twice a day for 10-16 days.
Placebo matching Seroquel XR
Placebo matching Seroquel XR dose 400-700 mg (in tablet form). Dose taken once a day for 10-16 days.
Placebo matching Seroquel IR
Placebo matching Seroquel IR dose 400-700 mg (in tablet form). Dose taken twice a day for 10-16 days.
Research Site, Vienna
Research Site, Middelfart
Research Site, Berlin
Research Site, Bochum
Research Site, Hamburg
Research Site, München
Research Site, Rottweil
Research Site, Giarre
Research Site, Genova
Research Site, Lido di Camaiore
Research Site, Barakaldo (vizcaya)
Research Site, Tivoli
Research Site, Sant'Arsenio
Research Site, Sassari
Research Site, Borgomanero
Research Site, Catania
Research Site, Roma
Research Site, Torre Annunziata
Research Site, Salamanca
Research Site, Zamora
Lead Sponsor
AstraZeneca
INDUSTRY